Search

Author/Creator Xu, Kaibo

3. A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects. (3rd August 2022)

Authors:
Liu, Zhengzhi; Gao, Zhenyue; Yang, Wei; Zhang, Lixiu; Xiao, Nan; Qu, Dongmei; Su, Zhengjie; Xu, Kaibo; Liu, Guangwen; Wang, Yanli; Ren, Qing; Yu, Shuang; Cheng, Yang; Zhou, Yannan; Deng, Qiaohuan; Zhao, Yicheng; Wang, Zeyu; Yang, Haimiao
Journal:
Expert opinion on drug metabolism and toxicology
Issue:
Volume 18:Number 7/8(2022)
Page Start:
519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects. (3rd July 2022)

Authors:
Xu, Zhongnan; Wang, Yanli; Liu, Guangwen; Chen, Jiahui; Wang, Wanhua; Cheng, Yang; Ren, Qing; Cui, Yingzi; Yang, Wei; Liu, Zhengzhi; Chen, Xuesong; Xue, Jinling; Chang, Tianying; Qu, Xinyao; Yu, Shuang; Zhou, Yannan; Xu, Kaibo; Su, Zhengjie; Deng, Qiaohuan; Zhao, Yicheng
Journal:
Expert opinion on investigational drugs
Issue:
Volume 31:Number 7(2022)
Page Start:
737
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Flexible energy load identification in intelligent manufacturing for demand response using a neural network integrated particle swarm optimization. (February 2022)

Authors:
Islam, Md Monirul; Sun, Zeyi; Qin, Ruwen; Hu, Wenqing; Xiong, Haoyi; Xu, Kaibo
Other Names:
Luo Xichun guest-editor.
Journal:
Proceedings of the Institution of Mechanical Engineers
Issue:
Volume 236:Number 4(2022)
Page Start:
1943
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗